Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy

Daisuke Kikuchi, Tsukasa Furuhata, Toshiro Iizuka, Akihiro Yamada, Satoshi Yamashita, Ai Fujimoto, Masanori Nakamura, Akira Matsui, Toshifumi Mitani, Osamu Ogawa, Shu Hoteya, Mitsuru Kaise

Research output: Contribution to journalArticle

Abstract

The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.

Original languageEnglish
Pages (from-to)1806-1811
Number of pages6
JournalGastroenterological Endoscopy
Volume54
Issue number6
Publication statusPublished - 2012 Jun
Externally publishedYes

Fingerprint

Gastrointestinal Endoscopy
Practice Management
Therapeutics
Endoscopic Hemostasis
Hemorrhage
Embolism
Informed Consent
Japan
Guidelines

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Cite this

Kikuchi, D., Furuhata, T., Iizuka, T., Yamada, A., Yamashita, S., Fujimoto, A., ... Kaise, M. (2012). Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy. Gastroenterological Endoscopy, 54(6), 1806-1811.

Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy. / Kikuchi, Daisuke; Furuhata, Tsukasa; Iizuka, Toshiro; Yamada, Akihiro; Yamashita, Satoshi; Fujimoto, Ai; Nakamura, Masanori; Matsui, Akira; Mitani, Toshifumi; Ogawa, Osamu; Hoteya, Shu; Kaise, Mitsuru.

In: Gastroenterological Endoscopy, Vol. 54, No. 6, 06.2012, p. 1806-1811.

Research output: Contribution to journalArticle

Kikuchi, D, Furuhata, T, Iizuka, T, Yamada, A, Yamashita, S, Fujimoto, A, Nakamura, M, Matsui, A, Mitani, T, Ogawa, O, Hoteya, S & Kaise, M 2012, 'Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy', Gastroenterological Endoscopy, vol. 54, no. 6, pp. 1806-1811.
Kikuchi D, Furuhata T, Iizuka T, Yamada A, Yamashita S, Fujimoto A et al. Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy. Gastroenterological Endoscopy. 2012 Jun;54(6):1806-1811.
Kikuchi, Daisuke ; Furuhata, Tsukasa ; Iizuka, Toshiro ; Yamada, Akihiro ; Yamashita, Satoshi ; Fujimoto, Ai ; Nakamura, Masanori ; Matsui, Akira ; Mitani, Toshifumi ; Ogawa, Osamu ; Hoteya, Shu ; Kaise, Mitsuru. / Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy. In: Gastroenterological Endoscopy. 2012 ; Vol. 54, No. 6. pp. 1806-1811.
@article{c1dd96bf6a6a41718878db8cb1795fd5,
title = "Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy",
abstract = "The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80{\%} of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20{\%} of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.",
author = "Daisuke Kikuchi and Tsukasa Furuhata and Toshiro Iizuka and Akihiro Yamada and Satoshi Yamashita and Ai Fujimoto and Masanori Nakamura and Akira Matsui and Toshifumi Mitani and Osamu Ogawa and Shu Hoteya and Mitsuru Kaise",
year = "2012",
month = "6",
language = "English",
volume = "54",
pages = "1806--1811",
journal = "Gastroenterological Endoscopy",
issn = "0387-1207",
publisher = "Japan Gastroenterological Endoscopy Society",
number = "6",

}

TY - JOUR

T1 - Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy

AU - Kikuchi, Daisuke

AU - Furuhata, Tsukasa

AU - Iizuka, Toshiro

AU - Yamada, Akihiro

AU - Yamashita, Satoshi

AU - Fujimoto, Ai

AU - Nakamura, Masanori

AU - Matsui, Akira

AU - Mitani, Toshifumi

AU - Ogawa, Osamu

AU - Hoteya, Shu

AU - Kaise, Mitsuru

PY - 2012/6

Y1 - 2012/6

N2 - The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.

AB - The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.

UR - http://www.scopus.com/inward/record.url?scp=84864267896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864267896&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84864267896

VL - 54

SP - 1806

EP - 1811

JO - Gastroenterological Endoscopy

JF - Gastroenterological Endoscopy

SN - 0387-1207

IS - 6

ER -